Does IPILIMUMAB Cause Metastatic malignant melanoma? 69 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 69 reports of Metastatic malignant melanoma have been filed in association with IPILIMUMAB (YERVOY). This represents 0.2% of all adverse event reports for IPILIMUMAB.
69
Reports of Metastatic malignant melanoma with IPILIMUMAB
0.2%
of all IPILIMUMAB reports
21
Deaths
26
Hospitalizations
How Dangerous Is Metastatic malignant melanoma From IPILIMUMAB?
Of the 69 reports, 21 (30.4%) resulted in death, 26 (37.7%) required hospitalization, and 8 (11.6%) were considered life-threatening.
Is Metastatic malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IPILIMUMAB. However, 69 reports have been filed with the FAERS database.
What Other Side Effects Does IPILIMUMAB Cause?
Death (3,710)
Malignant neoplasm progression (3,296)
Diarrhoea (2,557)
Off label use (2,097)
Colitis (1,988)
Pyrexia (1,796)
Rash (1,556)
Fatigue (1,447)
Intentional product use issue (1,329)
Nausea (1,169)
What Other Drugs Cause Metastatic malignant melanoma?
DABRAFENIB (449)
TRAMETINIB DIMETHYL SULFOXIDE (267)
TRAMETINIB (173)
SILDENAFIL (116)
TALIMOGENE LAHERPAREPVEC (109)
NIVOLUMAB (87)
PREDNISONE (77)
PEMBROLIZUMAB (74)
TADALAFIL (71)
INFLIXIMAB (61)
Which IPILIMUMAB Alternatives Have Lower Metastatic malignant melanoma Risk?
IPILIMUMAB vs IPRAGLIFLOZIN L-PROLINE
IPILIMUMAB vs IPRATROPIUM
IPILIMUMAB vs IPRATROPIUM\IPRATROPIUM ANHYDROUS
IPILIMUMAB vs IPTACOPAN
IPILIMUMAB vs IRBESARTAN